Shook Team Obtains Third Win This Year for Pharmacia
A Shook team has obtained their third win in a year for Pharmacia & Upjohn Co. LLC (Pharmacia), the maker of the corticosteroid drug Depo-Medrol® (methylprednisone acetate).
Shook Obtains Back-to-Back Wins for Medtronic In Product Liability Cases
Shook teams have obtained back-to-back wins for Medtronic, manufacturer of surgical and medical devices, persuading federal courts in Michigan and Texas to dismiss product liability claims against the company.
Eleventh Circuit Affirms Summary Judgment for Marketers of Enbrel
The Eleventh Circuit has affirmed a lower court’s grant of summary judgment in favor of the makers and marketers of the biologic drug Enbrel, finding that the plaintiffs' injury claims were barred by the learned intermediary doctrine and that the direct “patient labeling requirement” in FDA medication guidelines did not preempt application of the doctrine.
Second Circuit Affirms Dismissal of Mirena MDL
The U.S. Court of Appeals for the Second Circuit has affirmed the dismissal of litigation in which plaintiffs sought recovery for injuries they alleged were caused by Bayer’s intrauterine contraceptive system, Mirena®. Nearly 1,300 cases were certified as part of an MDL in 2013; the U.S. District Court for the Southern District of New York dismissed the cases in July 2016.
Shook Wins Mesh Verdict for Boston Scientific
Shook, Hardy & Bacon obtained a full defense verdict in a pelvic mesh case in Delaware when a jury found that Boston Scientific’s Lynx pelvic mesh sling was not unreasonably dangerous and that the company was not negligent in the product’s design; the jury declined to award the plaintiff any damages.